Regulatory Genome Development Limited completes $6m seed round to accelerate development of transformative regulatory data structures
Regulatory Genome Development Ltd (RegGenome), a commercial spin-out from the University of Cambridge, has today announced the completion of a $6 million seed funding round led by Evolution Equity Partners, with participation from AlbionVC, Cambridge Enterprise, and Mastercard. Richard Seewald, Managing Partner of Evolution Equity Partners, will join RegGenome’s board of directors.
RegGenome’s vision is to transform the way the world consumes regulatory information. The company provides structured machine-readable regulatory content that is dynamic, granular, and interoperable, all powered by AI-based textual information extraction techniques. This enables regulatory authorities to increase accessibility and dissemination of regulatory information and empowers organisations to deepen their regulatory intelligence and digitise their compliance and risk management processes.
“We are thrilled to be working with a group of investors that share our view that the world is rapidly entering into a period of regulatory uncertainty, requiring interoperable content to power the next generation of regulatory applications for the digital economy,” commented Management Practice Professor Robert Wardrop, Executive Chairman of RegGenome.
Richard Seewald, Founder & Managing Partner at Evolution Equity Partners, stated “We are excited to be partnering with Regulatory Genome and the tremendous team it has in place. Deepening regulatory intelligence and digitizing compliance and risk management functions utilizing machine learning and interoperability with cybersecurity, fintech and ESG presents tremendous opportunity for the company. I look forward to working with Robert Wardrop and the RegGenome team.”
“RegGenome is a superb example of how the University of Cambridge’s transformational intellectual property can be applied for global impact. RegGenome is primed to deliver a quantum leap in how regulatory content is shared and harnessed. Cambridge Enterprise has been an integral part of RegGenome from the outset, from enabling access to the required technology to investing in its funding. We are looking forward to seeing RegGenome’s vision come to life.” Dr Marcio Siqueira, Head of Physical Sciences, Cambridge Enterprise.
About Evolution Equity Partners:
Evolution Equity Partners, based in New York City, Palo Alto, London and Zurich makes investments in rapidly growing cybersecurity and enterprise software companies that safeguard our digital world. The firm was founded by investor and technology entrepreneurs Richard Seewald and Dennis Smith, who manage and lead the firm and its partners have been involved as founders, investors and as senior operating executives in leading software companies around the world. Evolution currently has over $1 billion of assets under management in a growing portfolio of market leading companies. Learn more at www.evolutionequity.com and follow us on LinkedIn and Twitter.
About AlbionVC:
AlbionVC helps build the future of enterprise and healthcare. With 26+ years’ experience in technology investments, the team focus on early stage partnerships across B2B software, deeptech and healthcare. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which is authorised and regulated by the Financial Conduct Authority. www.albion.vc
About Cambridge Enterprise:
Part of the University of Cambridge, Cambridge Enterprise supports academics, researchers, staff and students in achieving knowledge transfer and research impact. We do this by helping innovators, experts and entrepreneurs use commercial avenues to develop their ideas and expertise for the benefit of society, the economy, themselves and the University.
Liaising with organisations both locally and globally, we offer expert advice and support in commercialisation and social enterprise, including help with academic consultancy services, the protection, development and licensing of ideas, new company and social enterprise creation, and seed funding. For more information, please visit: www.enterprise.cam.ac.uk